PhaseII study of maintenance S-1 after chemotherapy with platinium+pemetrexed in advanced nonsquamous NSCLC.
- Conditions
- on Squamous Non Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000009275
- Lead Sponsor
- Kansai Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 22
Not provided
1)Interstitial pneumonia or pulmonary fibrosis on chest X-ray 2) History of serious drug allergy 3)Patients with active double cancer 4)Patients with pleural or pericardial effusion ,or ascites 5)Being treated with flucytosine. 6) History of serious infection 7)History of HBs antigen 8)Patients with significant complications a) Uncontrolled angina pectoris, myocardial infarction, heart failure within 3 months b)Uncontrolled diabetes or hypertension c)Current severe infection, or suspicious of severe infection d) Patients whose participation in the trial is judged to be inappropriate by the attending doctor. (e.g., ileus, bleeding tendency, diarrhea and varicella) 9 )Symptomatic brain metastases 10)Patients with pregnancy or lactation 11)patients whom it is judged to have difficulty in participation in study because of psychosis or neurologic disease 12)Patients whose participation in the trial is judged to be inappropriate by the attending doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression Free Survival
- Secondary Outcome Measures
Name Time Method Overall Survival, Response Rate, Safety